Background: Congenital anomalies are a major cause of co-morbidity in children.
| BACKG ROUND
Congenital anomalies are one of the leading causes of childhood mortality and morbidity, accounting for nearly 30% of all deaths in children aged under five years old in high-income countries. 1 Congenital anomalies can be caused by environmental factors (such as exposure to toxic agents), use of certain medications during pregnancy, factors associated with maternal health (eg, infections or chronic illness) and adverse health behaviours during pregnancy (eg, smoking or alcohol consumption), or by genetic effects, although causes of most congenital anomalies remain unexplained. 2 Monitoring congenital anomalies is important to detect emergence of hazards, but requires large, population-based datasets because congenital anomalies are relatively rare. Historically, congenital anomaly registries such those participating in the European Surveillance of Congenital Anomalies Network (EUROCAT) have been used for surveillance, [3] [4] [5] but they are resource-intensive to maintain and therefore often restricted to regional rather than national coverage. Consequently, individual congenital anomaly registries may lack power to detect very rare anomalies, or to examine regional variation in birth prevalence.
In contrast, whole-country birth cohorts created using administrative health datasets can be used to classify children with congenital anomalies based on clinical coding. These cohorts offer national coverage and sufficient power to compare prevalence of congenital anomalies across population subgroups at a relatively low cost. 6, 7 In settings with universal health care and limited private sector provision such as in the UK, national administrative data capture complete hospitalisation trajectories, including all hospital contacts across the nation. A further advantage of administrative health data is the availability of information on birth characteristics (eg gestational age and birthweight) and longitudinal follow-up (including outcomes such as mortality, surgical procedures, or hospital admission) among children with and without congenital anomalies. Birth cohorts from administrative health data can therefore be used to identify children with isolated or syndromic anomalies and those with multiple morbidities, explore risk factors for congenital anomalies, and assess risks of adverse outcomes and health care use in children with congenital anomalies compared with a population norm. Indicators of congenital anomalies based on clinical coding are also increasingly used to adjust for potential confounding effects of congenital anomalies. 8 However, there is a lack of evidence on the comparability of codes used to identify congenital anomalies in administrative databases and how outcomes differ.
We compared three different International Classification of Disease version 10 (ICD-10) code lists developed to identify congenital anomalies in health care or surveillance records: (a) the EUROCAT code list, developed for surveillance of congenital anomalies in Europe 9 ; (b) the Hardelid code list developed to identify children with chronic conditions (including a subgroup of congenital anomalies) admitted to hospitals in the National Health Service (NHS) in England, 10, 20 and (c) the Feudtner code list which aims to identify children with chronic complex conditions (with congenital anomalies as a subgroup) hospitalised in the United States (US). 11, 12 We used birth cohorts from linked administrative health databases in England and Scotland to evaluate the overlap between the code lists and compare prognostic risks for key outcomes.
administrative health data to study congenital anomalies should report sensitivity analyses using different code lists.
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Synopsis

Study question
How can we measure the prevalence of congenital anomalies in administrative health data?
What is already known
Diagnostic code lists are increasingly used to identify congenital anomalies in administrative health records.
Evidence is lacking on comparability of these code lists.
What this study adds
We compared prevalence of congenital anomalies, and risk of postnatal hospital admission and death in children aged less than two years old with a congenital anomaly using three code lists. Feudtner code list identified the least prevalent but most severe congenital anomalies.
The EUROCAT code list identified the largest and least severely affected group. Prevalence of congenital anomalies in administrative health records was influenced by thresholds for coding and for hospital admission; therefore, sensitivity analyses using alternative code lists identifying congenital anomalies of different severities are recommended.
| ME THODS
| Data sources
We developed whole-country birth cohorts using de-identified administrative health datasets in England and Scotland. We included singleton in-hospital livebirths to resident mothers. Follow-up information was obtained via linkage to birth records, hospital admission, and mortality records, and covered the period from birth until a child's second birthday or death, whichever occurred first.
In England, the birth cohort was based on birth admissions between 1 January 2003 and 31 December 2014 recorded in Hospital Episode Statistics (HES). 8, 13 HES is an administrative hospital admission database covering 97% of all births in England. 14 To assess deaths, we used Scottish Mortality Records (SMR99). The datasets were linked using study-specific identifiers generated by the data provider-the electronic Data Research and Innovation Service-who routinely links these datasets using the CHI-number, a unique identifier in the Scottish NHS. 16 Hospital admission records in SMR01 contained up to 6 diagnostic fields, and up to 12 diagnoses in SBR. Up to 11 causes of death were available in SMR99. 17 In both countries, diagnostic information and causes of death were recorded using ICD-10 codes during the study period. 10 Clinical coders in each hospital translate medical notes into diagnostic codes once patient care has finished. All coders are required to complete national accreditation training to ensure standardisation of recorded information between hospitals. Only information explicitly stated in the notes can be recorded; therefore, coding sensitivity can vary according to the quality and details recorded in medical notes. 14, 18 In both countries, causes of death are coded at death registration.
| Code lists
We evaluated three congenital anomaly code lists based on ICD-10 codes. The EUROCAT code list was developed by the EUROCAT network to classify unstandardized text in registries for congenital anomaly surveillance in Europe. The EUROCAT list focuses on conditions diagnosed during pregnancy or in infancy, covering most codes from Chapter 17 of ICD-10 ("Congenital malformations, deformations, and chromosomal abnormalities" 19 ) and five additional codes from other ICD-10 chapters. Minor or unspecified anomalies are excluded from the list. 9 The second code list was developed by Hardelid et al 10 to identify children with chronic conditions, including congenital anomalies, who were admitted to NHS hospitals. The code list was derived using previous reports (including EUROCAT and Feudtner) and iterative review by a clinical panel to identify chronic conditions expected to require medical follow-up for more than 12 months in more than 50% of cases. 20 We used a subgroup of Hardelid codes from Chapter 17 of ICD-10 (that is, codes starting with "Q") to indicate congenital anomalies.
Third, we used the code list of paediatric complex chronic conditions developed by Feudtner et al to indicate conditions likely to last at least 12 months and involve multiple organ systems or require specialist paediatric care/hospitalisation in a tertiary care centre. 21 The list was originally based on ICD version 9 and was later updated to ICD-10. 11 We indicated congenital anomalies using a subgroup of codes from Chapter 17 of ICD-10 included in the Feudtner code list.
For Hardelid and Feudtner code lists, we did not include congenital infections (recorded in chapter 16 of ICD-10), which were included in the EUROCAT code list. All three code lists are provided in Table   S1 in Appendix S1, together with additional information about code selection criteria.
| Outcomes
The presence of congenital anomalies was indicated if at least one appropriate ICD-10 code in the relevant code list was recorded as primary or subsidiary diagnosis at birth, during any hospital admission, or as any cause of death on the death record, before two years of age. This length of follow-up enabled us to capture anomalies which may not be obvious at birth and diagnosed at later age.
| Statistical analyses
We calculated the prevalence of congenital anomalies according to each code list (with 95% confidence intervals, 95% CI), defined as the number of children with at least one congenital anomaly divided by all livebirths in the cohorts. To assess trends in prevalence of congenital anomalies over time in each country, we estimated risk ratios (RR) for congenital anomalies by year of birth using log-binomial regression models. 22 We determined the overlap in the number of children identified between the code lists, and we compared the number of overlapping ICD-10 codes included in the three code lists. We determined the number of children identified using each code list by ICD-10 subchapter, and we listed five most commonly recorded ICD-10 codes for congenital anomalies included in each code list per country.
We compared prognostic outcomes between the code lists in each country to assess differences in severity of congenital anomalies identified by each list. We estimated the proportion of children with a readmission in the first two years of life after birth (defined as the number of children with at least one hospital readmission after postnatal discharge divided by all births captured by a given congenital anomaly code list) and under-2 mortality rate (defined as the number of all deaths in children aged less than 2 years old per 1000 births captured by a given congenital anomaly code list).
We defined hospital admission as a continuous period in hospital; therefore, admissions and transfers within one day were treated as part of the same hospital stay. 10 We counted all hospital admissions after birth including those before a congenital anomaly diagnosis was recorded. We estimated RR for postnatal readmission and mortality for each congenital anomaly code list over time and relative to children with no recorded anomalies using log-binomial regression models. We report proportions of children in the two countries by number of postnatal readmissions (classified as 0, 1, 2-3, 4+) and congenital anomaly code list. We also report number and proportion of child deaths by age at death (0-27 days, 28-364 days, and 1-2 years). All analyses were performed using Stata SE version 15.0.
| Sensitivity analyses
We compared the distribution of age at first recorded diagnosis of a congenital anomaly to examine whether anomalies captured by the code lists differed in timing of detection in hospital. Age at first diagnosis was grouped as 0-27 days, 28-89 days, 90-364 days, and 1-2 years. English data enabled further breakdown into diagnosis around the time of birth, in the first week (1-6 days) and at 7-27 days.
Since 2004, hospitals in England charge tariffs based on recorded diagnoses, thereby creating financial incentives for hospitals to improve coding of more complex patients. 14 (EUROCAT) to 3.1% (Hardelid) and 1.8% (Feudtner) . Equivalent figures for Scotland were 3.7%, 3.0%, and 1.5% (Table 1 ). In England, prevalence of congenital anomalies increased by 2.7% per year using the Hardelid code list (RR = 1.03, 95% CI: 1.03, 1.03), by 3.0% using EUROCAT (RR = 1.03, 95% CI: 1.03, 1.03); the increase was slowest for congenital anomalies identified using Feudtner code list (2.1%, RR = 1.02, 95% CI: 1.02, 1.02, Table 1 and Figure 1A ). In Scotland, annual increases in the prevalence of congenital anomalies were observed only for Hardelid and EUROCAT code lists, but were lower than in England (1.6%, RR = 1.02, 95% CI: 1.01, 1.02 and 1.7%, RR = 1.02, 95% CI: 1.01, 1.02, respectively). Table 2 ).
| Overlap between the code lists
All three code lists covered all congenital anomalies of the nervous system included in ICD-10, and largely overlapping codes for congenital anomalies of the respiratory and urinary systems and chromosomal anomalies (Table S1 ), leading to comparable absolute numbers of children identified with these conditions between the code lists (Table S2 ). Congenital anomalies of circulatory system covered the highest number of children identified using each code list (Table S2) ; patient ductus arteriosus, and atrial and ventricular septal defects were included in the five commonly recorded congenital anomalies for Hardelid and EUROCAT code lists (Table S3 ).
In both countries, congenital malformations of the skin were the most common condition diagnosed using the EUROCAT code list, and patent ductus arteriosus was the most frequently recorded condition based on Hardelid code list, while congenital hydronephrosis (England) and congenital laryngeal stridor (Scotland) were the most frequently recorded conditions using the Feudtner codes (Table S3) 
| Postnatal readmissions
The proportion of children with any hospital readmission after postnatal discharge and before age 2 years was similar between the two countries and was consistent with a gradient of severity ( Table 1) . in Scotland, to a high of 29.0% (England) and 30.9% (Scotland) for children with congenital anomalies identified using the Feudtner code list (Figure 2 ).
| Mortality
The mortality rates before 2 years old were highest for children iden- (Table S4 ).
| Sensitivity analyses
The majority of children with congenital anomalies across all code lists were identified in the first month of life; in England, 56.4%-67.4% of congenital anomalies were first recorded at birth. The EUROCAT codes were most likely to be recorded during the first month of life (accounting for 76.1% and 75.1% of children diagnosed using EUROCAT code list in England and Scotland, respectively), whereas Feudtner codes were least likely to be recorded in that time (69.0% and 67.8%, Table 3 ).
In England, the mean number of recorded ICD-10 codes per hospital admission increased from 2.0 diagnostic codes per hospital admission in 2003 to 2.5 in 2013. The median number of diagnostic codes remained at 2 throughout the study period in England (Table S5 ).
| COMMENT
| Principal findings
The prevalence of congenital anomalies ranged between 1.8% and 4.1% in England and between 1. 
| Strengths of the study
A strength of our study is our use of national birth cohorts based on administrative hospital databases for two UK countries, with similar NHS health systems. As 97% of deliveries occur in NHS hospitals, our data enabled us to calculate nationally representative prevalence of congenital anomalies, overcoming limitations of regional congenital anomaly registers. Whole-country coverage allowed us to compare long-term outcomes in children with congenital anomalies relative to children with no anomalies.
National birth cohorts from administrative databases in England
and Scotland offer an excellent, low cost resource for studying the health of children with congenital anomalies and associated risk factors, due to the availability of additional birth details (such as birthweight and gestational age), longitudinal follow-up through linkage to hospital and mortality records, 14 and possibility of linking babies to mother's records (eg to obtain information about maternal infections during pregnancy). 13
| Limitations of the data
One limitation is that we could not validate the accuracy of hospital records indicating congenital anomalies. We did not have permissions or capacity to validate hospital records directly by accessing case notes. Nor could we determine record accuracy by a comparison with a reference standard, for example through record linkage between high-quality congenital anomaly registry data and hospital TA B L E 2 Overlap in number of children identified and ICD-10 codes included in each congenital anomaly code list in England and Scotland Lastly, our study was limited to singleton livebirths only. In English data, same sex siblings from a multiple births are more likely to be falsely allocated the same study-specific identifier. To minimise potential bias from linkage error, we excluded multiple births from the analyses. 15 Multiple births, however, have a higher risk of most congenital anomalies, including more severe congenital anomalies of central nervous system, cardiovascular and musculo-skeletal systems. 30 The national prevalence of congenital anomalies is therefore likely to be slightly higher than that based on singleton births only.
| Interpretation
The We have shown that administrative health data can be used to derive nationally representative figures for prevalence of congenital anomalies which require hospital care or are likely to be diagnosed at birth. The estimated prevalence rates need to be interpreted with caution, however, as they may be affected by coding practices and thresholds for hospital admissions in a given country. For example, we showed differing prevalence rates of congenital anomalies in England and Scotland consistent with the number of diagnostic codes available for each admission (ie higher prevalence in England, where 20 diagnostic codes could be recorded, compared with six in Scotland). The risk of postnatal readmission to hospital was higher in Scotland, while prevalence of congenital anomaly was lower there. This suggests that children with congenital anomalies identified in Scotland might have been more severely affected, or that minor anomalies were less often recorded due to the limited number of diagnosis fields available in Scottish data. We observed increases in the prevalence of congenital anomalies in England over time, where financial incentives for increased coding depth are present. We did not observe comparable increase in Scotland. Increases over time in England could also partly reflect declining thresholds for hospital admissions, suggested by increases in the risk of hospital readmission after birth both for children with and without congenital anomalies over time. These findings illustrate that trends and inter-country comparisons of congenital anomaly prevalence based on hospital admission data need to be interpreted with caution and sensitivity analyses using multiple code lists are recommended.
| CON CLUS IONS
Multiple code lists are available to monitor the prevalence and type of congenital anomalies and identify children with different severities. Furthermore, different thresholds for coding and hospital admissions can influence prevalence rates and measured risk of 
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